Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs
The actions of many drugs involve enzyme inhibition. This is exemplified by the inhibitors of monoamine oxidases (MAO) and the cholinsterases (ChE) that have been used for several pharmacological purposes. This review describes key principles and approaches for the reliable determination of enzyme a...
Saved in:
Published in | Molecules (Basel, Switzerland) Vol. 22; no. 7; p. 1192 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
15.07.2017
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The actions of many drugs involve enzyme inhibition. This is exemplified by the inhibitors of monoamine oxidases (MAO) and the cholinsterases (ChE) that have been used for several pharmacological purposes. This review describes key principles and approaches for the reliable determination of enzyme activities and inhibition as well as some of the methods that are in current use for such studies with these two enzymes. Their applicability and potential pitfalls arising from their inappropriate use are discussed. Since inhibitor potency is frequently assessed in terms of the quantity necessary to give 50% inhibition (the IC
value), the relationships between this and the mode of inhibition is also considered, in terms of the misleading information that it may provide. Incorporation of more than one functionality into the same molecule to give a multi-target-directed ligands (MTDLs) requires careful assessment to ensure that the specific target effects are not significantly altered and that the kinetic behavior remains as favourable with the MTDL as it does with the individual components. Such factors will be considered in terms of recently developed MTDLs that combine MAO and ChE inhibitory functions. |
---|---|
AbstractList | The actions of many drugs involve enzyme inhibition. This is exemplified by the inhibitors of monoamine oxidases (MAO) and the cholinsterases (ChE) that have been used for several pharmacological purposes. This review describes key principles and approaches for the reliable determination of enzyme activities and inhibition as well as some of the methods that are in current use for such studies with these two enzymes. Their applicability and potential pitfalls arising from their inappropriate use are discussed. Since inhibitor potency is frequently assessed in terms of the quantity necessary to give 50% inhibition (the IC
50
value), the relationships between this and the mode of inhibition is also considered, in terms of the misleading information that it may provide. Incorporation of more than one functionality into the same molecule to give a multi-target-directed ligands (MTDLs) requires careful assessment to ensure that the specific target effects are not significantly altered and that the kinetic behavior remains as favourable with the MTDL as it does with the individual components. Such factors will be considered in terms of recently developed MTDLs that combine MAO and ChE inhibitory functions. The actions of many drugs involve enzyme inhibition. This is exemplified by the inhibitors of monoamine oxidases (MAO) and the cholinsterases (ChE) that have been used for several pharmacological purposes. This review describes key principles and approaches for the reliable determination of enzyme activities and inhibition as well as some of the methods that are in current use for such studies with these two enzymes. Their applicability and potential pitfalls arising from their inappropriate use are discussed. Since inhibitor potency is frequently assessed in terms of the quantity necessary to give 50% inhibition (the IC50 value), the relationships between this and the mode of inhibition is also considered, in terms of the misleading information that it may provide. Incorporation of more than one functionality into the same molecule to give a multi-target-directed ligands (MTDLs) requires careful assessment to ensure that the specific target effects are not significantly altered and that the kinetic behavior remains as favourable with the MTDL as it does with the individual components. Such factors will be considered in terms of recently developed MTDLs that combine MAO and ChE inhibitory functions. The actions of many drugs involve enzyme inhibition. This is exemplified by the inhibitors of monoamine oxidases (MAO) and the cholinsterases (ChE) that have been used for several pharmacological purposes. This review describes key principles and approaches for the reliable determination of enzyme activities and inhibition as well as some of the methods that are in current use for such studies with these two enzymes. Their applicability and potential pitfalls arising from their inappropriate use are discussed. Since inhibitor potency is frequently assessed in terms of the quantity necessary to give 50% inhibition (the IC value), the relationships between this and the mode of inhibition is also considered, in terms of the misleading information that it may provide. Incorporation of more than one functionality into the same molecule to give a multi-target-directed ligands (MTDLs) requires careful assessment to ensure that the specific target effects are not significantly altered and that the kinetic behavior remains as favourable with the MTDL as it does with the individual components. Such factors will be considered in terms of recently developed MTDLs that combine MAO and ChE inhibitory functions. |
Author | Tipton, Keith F Ramsay, Rona R |
AuthorAffiliation | 1 Biomedical Sciences Research Complex, University of St Andrews, St Andrews KY16 8QP, UK 2 School of Biochemistry and Immunology, Trinity College, Dublin 2, Ireland; ktipton@tcd.ie |
AuthorAffiliation_xml | – name: 1 Biomedical Sciences Research Complex, University of St Andrews, St Andrews KY16 8QP, UK – name: 2 School of Biochemistry and Immunology, Trinity College, Dublin 2, Ireland; ktipton@tcd.ie |
Author_xml | – sequence: 1 givenname: Rona R surname: Ramsay fullname: Ramsay, Rona R email: rrr@st-andrews.ac.uk organization: Biomedical Sciences Research Complex, University of St Andrews, St Andrews KY16 8QP, UK. rrr@st-andrews.ac.uk – sequence: 2 givenname: Keith F surname: Tipton fullname: Tipton, Keith F email: ktipton@tcd.ie organization: School of Biochemistry and Immunology, Trinity College, Dublin 2, Ireland. ktipton@tcd.ie |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28714881$$D View this record in MEDLINE/PubMed |
BookMark | eNplkktvEzEUhUeoiD7gB7BBltiwCfj6MeNhgRSlaYlUVAl1b3nGdxJHM3awZ9KGPf-baZNWLaxsHZ_72ef6nmZHPnjMsvdAP3Ne0i9daLEeWkyM0QKgZK-yExCMTjgV5dGz_XF2mtKaUgYC5JvsmKkChFJwkv2ZpoQpdeh7Ehoy9793HZKFX7nK9S74r2RKfuLW4S25df2KzO9MtxlvJE0MHelXSM5xi23YPBJ-BB9M5zyS6ztnTUJivCWzVWhHLfUY76UDP8QdOY_DMr3NXjemTfjusJ5lNxfzm9n3ydX15WI2vZrUUkA_ESCoBQQDzEpecZCWW54LU9KCVqayUKIqQSlWyFrJnIJqckHBohSmavhZtthjbTBrvYmuM3Gng3H6QQhxqU3sXd2itlhxKylTpaxFwa0pqG2UaFSDTU5rO7K-7VmboerQ1mP8aNoX0Jcn3q30Mmx1DpIxkY-ATwdADL-GsTW6c6nGtjUew5D0-J0USq5kOVo__mNdhyH6sVOaAX0ImsvRBXtXHUNKEZunxwDV9_Oi_5uXsebD8xRPFY8Dwv8CKB_Byg |
CitedBy_id | crossref_primary_10_3390_ijms23095072 crossref_primary_10_1016_j_foodres_2020_109129 crossref_primary_10_1016_j_jsps_2023_101939 crossref_primary_10_1515_znc_2021_0058 crossref_primary_10_3390_molecules25214945 crossref_primary_10_3390_plants10040698 crossref_primary_10_1007_s42452_019_0335_5 crossref_primary_10_3839_jabc_2018_027 crossref_primary_10_2174_0115734080275060231228093149 crossref_primary_10_1007_s13399_021_01692_7 crossref_primary_10_1021_acs_chemrev_8b00271 crossref_primary_10_1080_14756366_2022_2036737 crossref_primary_10_3390_ijms22147472 crossref_primary_10_1111_febs_14994 crossref_primary_10_1016_j_bioorg_2021_105301 crossref_primary_10_1016_j_indcrop_2018_02_040 crossref_primary_10_2174_0115734080273835231127045336 crossref_primary_10_1055_a_1557_7379 crossref_primary_10_1080_14756366_2022_2150762 crossref_primary_10_1515_znc_2021_0223 crossref_primary_10_1016_j_chroma_2023_464330 crossref_primary_10_1007_s10930_022_10063_8 crossref_primary_10_1016_j_bmcl_2019_01_016 crossref_primary_10_1016_j_foodres_2020_109371 crossref_primary_10_1080_14786419_2021_1872075 crossref_primary_10_1007_s11274_021_03118_y crossref_primary_10_1186_s40360_021_00521_x crossref_primary_10_2174_1573408019666230807161244 crossref_primary_10_1002_jcp_28626 crossref_primary_10_1016_j_bcp_2018_01_044 crossref_primary_10_1016_j_indcrop_2019_03_033 crossref_primary_10_1134_S1063074018020037 crossref_primary_10_1021_acs_jchemed_2c00392 crossref_primary_10_1515_tjb_2022_0161 crossref_primary_10_1515_revic_2023_0007 crossref_primary_10_1039_D0FO01306D crossref_primary_10_1080_00032719_2020_1821700 crossref_primary_10_3390_molecules27082468 crossref_primary_10_1016_j_eujim_2020_101272 crossref_primary_10_1016_j_bpj_2020_08_020 crossref_primary_10_1016_j_heliyon_2022_e09501 crossref_primary_10_1039_D3MD00399J crossref_primary_10_1007_s12649_021_01537_4 crossref_primary_10_3390_bios11090322 crossref_primary_10_1002_ddr_21594 crossref_primary_10_1158_1535_7163_MCT_23_0358 crossref_primary_10_1016_j_snb_2022_132434 crossref_primary_10_1002_jmr_3020 crossref_primary_10_1080_07391102_2023_2196703 crossref_primary_10_1016_j_mencom_2022_07_001 crossref_primary_10_1021_acs_est_2c01433 crossref_primary_10_2174_1389557519666191018170908 crossref_primary_10_3390_molecules26071902 crossref_primary_10_4014_jmb_2105_05003 crossref_primary_10_1002_jsfa_10216 crossref_primary_10_1080_07391102_2023_2292294 crossref_primary_10_1007_s12195_019_00572_5 crossref_primary_10_3390_antiox10111830 crossref_primary_10_1039_D1AN00531F crossref_primary_10_3390_chemistry3030069 crossref_primary_10_1002_slct_202300461 crossref_primary_10_1002_slct_202401406 crossref_primary_10_1002_smll_202309481 crossref_primary_10_2174_1389557519666190719143112 crossref_primary_10_1016_j_molliq_2018_01_014 crossref_primary_10_1016_j_chembiol_2020_04_007 crossref_primary_10_1021_acsmedchemlett_9b00477 crossref_primary_10_1186_s13765_024_00878_7 crossref_primary_10_1016_j_procbio_2021_10_014 crossref_primary_10_3390_plants10102046 crossref_primary_10_20964_2022_12_74 crossref_primary_10_1016_j_bmcl_2018_06_023 crossref_primary_10_3390_ph14020133 crossref_primary_10_1007_s41207_023_00402_1 crossref_primary_10_3389_fnins_2023_1148258 crossref_primary_10_7554_eLife_36307 crossref_primary_10_1016_j_fbio_2024_104209 crossref_primary_10_1016_j_ijbiomac_2020_02_144 crossref_primary_10_1080_07391102_2023_2276317 crossref_primary_10_1016_j_aca_2024_342268 crossref_primary_10_1107_S2052252519016142 crossref_primary_10_1016_j_foodchem_2022_134580 crossref_primary_10_1016_j_bmcl_2018_01_049 crossref_primary_10_3389_fmicb_2018_00916 crossref_primary_10_1016_j_sajb_2022_06_067 crossref_primary_10_4236_abc_2021_115013 crossref_primary_10_3389_fphar_2020_00831 crossref_primary_10_1016_j_indcrop_2022_114580 crossref_primary_10_1007_s00249_021_01530_8 crossref_primary_10_1007_s10895_024_03792_9 crossref_primary_10_1007_s11418_023_01778_8 crossref_primary_10_2174_1570180818666210413131108 crossref_primary_10_1016_j_bioorg_2020_103722 crossref_primary_10_1186_s41110_023_00249_0 crossref_primary_10_1016_j_fct_2021_112327 crossref_primary_10_1016_j_crvi_2019_07_004 crossref_primary_10_1021_acsomega_3c06532 crossref_primary_10_1007_s43440_020_00070_w crossref_primary_10_1124_pharmrev_121_000524 crossref_primary_10_3390_molecules26154576 crossref_primary_10_3390_foods11142095 crossref_primary_10_3390_biophysica1040028 crossref_primary_10_1021_acschemneuro_0c00706 crossref_primary_10_2174_1871524923666230908094645 crossref_primary_10_1016_j_bcp_2018_08_001 crossref_primary_10_2174_1871524923666230417094549 crossref_primary_10_1016_j_foodres_2020_109970 crossref_primary_10_1007_s13738_019_01848_3 crossref_primary_10_2174_1389557521666211027104638 crossref_primary_10_1016_j_phrs_2022_106126 crossref_primary_10_1007_s11064_020_03057_4 crossref_primary_10_1016_j_chroma_2019_460438 crossref_primary_10_2174_0115734080271639231030093152 crossref_primary_10_3390_molecules25245908 crossref_primary_10_3389_fimmu_2022_889950 crossref_primary_10_1109_COMST_2020_3008819 crossref_primary_10_3390_cryst12010044 crossref_primary_10_1007_s13205_020_02630_6 crossref_primary_10_1002_cbdv_202301271 crossref_primary_10_1615_IntJMedMushrooms_2023050127 crossref_primary_10_1016_j_ijbiomac_2019_06_167 crossref_primary_10_1108_MMMS_01_2020_0003 crossref_primary_10_3390_foods11071010 crossref_primary_10_1007_s00702_018_1881_5 crossref_primary_10_1002_ardp_201800352 crossref_primary_10_1016_j_jinorgbio_2020_111070 crossref_primary_10_1016_j_colsurfb_2021_111688 crossref_primary_10_1016_j_lwt_2021_111382 crossref_primary_10_1007_s13738_021_02416_4 crossref_primary_10_1186_s40169_017_0181_2 crossref_primary_10_1016_j_fitote_2018_07_015 crossref_primary_10_3724_abbs_2023098 crossref_primary_10_3390_molecules24162959 crossref_primary_10_1007_s00702_018_1861_9 crossref_primary_10_1016_j_bcab_2021_102235 crossref_primary_10_1016_j_saa_2024_124160 crossref_primary_10_1016_j_bmc_2019_07_049 crossref_primary_10_1016_j_sajb_2020_06_006 crossref_primary_10_3390_antibiotics11020200 crossref_primary_10_3923_ijbc_2022_8_19 crossref_primary_10_1002_adfm_202310129 crossref_primary_10_1007_s00726_018_2675_7 crossref_primary_10_1007_s42452_020_3107_3 |
Cites_doi | 10.1016/0197-0186(92)90189-X 10.1038/nrn1035 10.1517/13543776.2015.1090973 10.1021/ar00056a003 10.1021/bi7019707 10.2144/01301st04 10.1006/abio.1993.1464 10.1021/bi00060a003 10.3389/fnins.2016.00265 10.1006/bbrc.1995.1079 10.1515/znc-2006-3-423 10.1016/S0361-9230(98)00111-7 10.1016/j.bcp.2015.01.017 10.1111/j.1471-4159.2005.03573.x 10.1212/WNL.0b013e318216eb7b 10.5694/j.1326-5377.1949.tb37429.x 10.1016/j.neuropharm.2016.10.028 10.1517/17460441.2012.729037 10.1021/acschemneuro.6b00377 10.1016/j.ejmech.2016.03.084 10.1016/j.bmc.2007.05.021 10.1111/j.1471-4159.1979.tb02296.x 10.1016/j.abb.2007.05.006 10.1016/S0896-6273(01)00584-0 10.3390/ijms12042631 10.1007/s12031-008-9139-6 10.1017/S1461145705005833 10.1007/s00441-006-0239-8 10.1074/jbc.M210241200 10.1021/ja101557k 10.1016/j.tiv.2009.11.023 10.1002/0471141755.tx0421s30 10.1002/chin.199743321 10.1073/pnas.1301814110 10.1021/jm8002075 10.1002/14651858.CD005593 10.1016/j.cbi.2012.10.024 10.1111/j.1600-0773.1981.tb03263.x 10.1039/C6RA03455A 10.1146/annurev.neuro.22.1.197 10.12659/MSM.892982 10.1016/0006-2952(82)90327-6 10.1006/abio.1996.0041 10.1038/nsb732 10.1038/aps.2016.78 10.1021/jm070677y 10.1016/0006-2952(82)90575-5 10.3389/fnins.2016.00177 10.3233/JAD-2011-111241 10.1039/c0an00168f 10.1016/j.ab.2016.06.020 10.1016/j.jmb.2004.02.032 10.1089/ars.2011.4279 10.1016/j.ejmech.2016.03.002 10.3389/fnins.2016.00205 10.3390/molecules21030362 10.2210/pdb2bxr/pdb 10.1016/0006-2952(80)90202-6 10.1111/j.1432-1033.1981.tb06447.x 10.1016/j.bmc.2017.02.027 10.1007/s00702-011-0657-y 10.1126/science.7838 10.1016/0223-5234(90)90131-L 10.1177/000456327901600114 10.1016/j.ab.2007.07.023 10.1007/s00406-006-0660-8 10.1002/14651858.CD003155 10.1007/s10822-014-9816-1 10.3390/ijms15069809 10.1042/bj1250521 10.1016/j.talanta.2012.10.085 10.2174/0929867322666150114163051 10.1016/B978-0-12-386467-3.00002-9 10.1016/0005-2744(69)90420-3 10.1111/j.1365-2125.2006.02627.x 10.1002/1098-2299(200007/08)50:3/4<216::AID-DDR4>3.0.CO;2-Z 10.1042/bj2250825 10.1021/jm800132g 10.1023/B:CEMN.0000012725.31108.4a 10.1007/s00044-013-0704-3 10.2174/156720506779025288 10.1021/ja0512780 10.1002/rcm.1415 10.1016/j.pneurobio.2016.04.001 10.1016/j.pneurobio.2015.07.002 10.3891/acta.chem.scand.15-1386 10.1042/bj1150465 10.1021/jm0400810 10.1042/bj1110487 10.1016/0006-2952(89)90522-4 10.1159/000065054 10.1007/s00702-007-0692-x 10.2174/1570159X11311030006 10.1081/BIO-200027497 10.1136/pgmj.23.260.280 10.5041/RMMJ.10014 10.1002/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO;2-1 10.1016/j.bmc.2016.12.029 10.1111/febs.13260 10.3389/fnins.2016.00375 10.1111/j.1527-3458.2003.tb00245.x 10.2174/138945012799499794 10.1016/B978-0-12-386467-3.00003-0 10.1021/bi8002814 10.1016/0003-2697(78)90344-5 10.1016/j.ejmech.2013.12.028 10.1007/s11064-010-0238-8 10.1016/j.pneurobio.2015.12.003 10.1042/bj3140817 10.1016/j.cbi.2016.04.009 10.1016/0076-6879(79)63004-5 10.1016/j.bbapap.2014.03.006 10.1016/0006-2952(74)90251-2 10.5607/en.2013.22.1.1 10.1016/j.bmc.2005.02.061 10.1016/0006-2952(95)00145-P 10.1073/pnas.0601515103 10.1021/ac60220a031 10.1007/BF00978365 10.1002/j.1460-2075.1992.tb05439.x 10.1002/ejoc.201100873 10.1111/j.1432-1033.1984.tb08079.x 10.3389/fnins.2016.00541 10.1016/j.bmc.2015.04.009 10.1016/S0021-9258(17)45254-9 10.4049/jimmunol.176.1.27 10.1016/j.mex.2014.10.010 10.1038/nrd892 10.1016/0005-2744(81)90034-6 10.1001/archpsyc.63.11.1209 10.1016/j.vascn.2015.07.002 10.1016/j.cclet.2008.05.032 10.2741/3069 10.1016/j.bmc.2014.12.063 10.1016/j.phrs.2010.09.001 10.1517/13543776.2014.982535 10.1073/pnas.85.13.4934 10.1042/bj0780769 10.1016/S0306-4522(96)83013-2 10.1038/sj.bjp.0707430 10.1038/srep37574 10.1016/j.pisc.2014.02.012 10.1016/0009-8981(77)90267-4 10.1016/j.ejmech.2016.09.041 10.1042/bj2090235 10.1016/S0009-8981(99)00144-8 10.1016/j.ab.2006.09.035 10.1016/S0003-2697(02)00506-7 10.1254/jjp.89.7 10.1515/znc-2007-1-225 10.1021/bi00708a010 10.1073/pnas.0508575102 10.1016/j.cbi.2008.05.035 10.1101/lm.026070.112 10.2174/1567205054367838 10.1038/npp.2014.214 10.1126/science.1678899 10.1586/14737175.2016.1150783 10.1042/bj2600625 10.1016/S0968-0896(99)00149-2 10.1212/WNL.42.5.946 10.1016/j.talanta.2009.12.052 10.1038/sj.bjc.6601361 10.1093/emboj/cdg005 10.1016/0006-2952(94)90123-6 10.1007/s00702-011-0616-7 10.1021/acschemneuro.5b00040 10.1038/bjp.2008.185 10.1111/j.1742-4658.2007.06238.x 10.1042/bj0460451 10.1042/bj1350101 10.3390/ijms17040525 10.1093/ijnp/pyv078 10.1073/pnas.68.8.1678 10.2174/138161206775193127 10.1371/journal.pone.0074916 10.1136/jmg.7.4.351 10.1016/j.ejmech.2015.03.040 10.1080/14756366.2016.1186019 10.1016/j.ejmech.2014.01.060 10.1111/j.1471-4159.1983.tb11312.x 10.1016/j.bmc.2016.02.023 10.1016/j.pneurobio.2016.03.004 10.1021/acs.jmedchem.6b00562 10.1021/acs.analchem.5b04303 10.1155/2012/728983 10.1042/bj1290197 10.3389/fnins.2016.00294 10.1002/(SICI)1096-9861(19980413)393:3<374::AID-CNE8>3.0.CO;2-Z 10.1021/bi020016x 10.1523/JNEUROSCI.2037-10.2010 10.1002/syn.890180203 10.1002/jlcr.3247 10.1074/jbc.M111.241422 10.1023/A:1006982732681 10.1007/s00204-017-1946-5 10.3233/JAD-2007-11412 10.1016/S1570-9639(03)00062-1 10.1042/bj2400379 10.1289/ehp.9087245 10.1016/S0021-9258(18)50153-8 10.1002/0471227617 10.1016/B978-0-12-386467-3.00009-1 10.1016/j.bmc.2011.12.042 10.1016/j.cbpb.2011.02.002 10.1038/nrn1883 10.1021/cr900214c 10.1016/S0021-9258(18)69497-9 10.1021/ac60122a029 10.1016/0197-0186(90)90154-L 10.1111/j.1527-3458.2001.tb00205.x 10.1021/ja058519o 10.1021/jm200853t 10.1038/35067589 10.1042/bj2270843 10.1126/science.3875898 10.2165/00139709-200625020-00004 10.1021/acs.jmedchem.5b00599 10.1016/j.pharmthera.2014.02.010 10.1523/JNEUROSCI.12-05-01977.1992 10.1074/jbc.M109.004952 10.1159/000151112 10.1038/nprot.2006.402 10.1002/dta.337 10.1016/0006-2952(61)90145-9 10.1097/00004714-200212000-00012 |
ContentType | Journal Article |
Copyright | 2017. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2017 by the authors. 2017 |
Copyright_xml | – notice: 2017. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2017 by the authors. 2017 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.3390/molecules22071192 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Open Access: DOAJ - Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: Health & Medical Collection (Proquest) url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1420-3049 |
ExternalDocumentID | oai_doaj_org_article_deb3d502895c473da70df84f8fef60cd 10_3390_molecules22071192 28714881 |
Genre | Journal Article Review |
GroupedDBID | --- 0R~ 123 2WC 3V. 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH ABDBF ABJCF ABUWG ACGFO ACIWK ACPRK AEGXH AENEX AFKRA AFPKN AFRAH AFZYC AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CGR CS3 CUY CVF D1I DIK DU5 E3Z EBD ECM EIF EMOBN ESTFP ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE HZ~ I09 IPNFZ KB. KQ8 LK8 M1P M7P MODMG M~E NPM O-U O9- OK1 P2P PDBOC PIMPY PQQKQ PROAC PSQYO RIG RPM SV3 TR2 TUS UKHRP ~8M AAYXX CITATION 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c541t-4140d1e1a12d53b315d3d364a9070babd19e89188275c856018f6401de54abf3 |
IEDL.DBID | RPM |
ISSN | 1420-3049 |
IngestDate | Fri Jul 05 11:56:36 EDT 2024 Tue Sep 17 20:52:37 EDT 2024 Thu Jul 25 09:29:53 EDT 2024 Thu Oct 10 17:34:18 EDT 2024 Fri Aug 23 02:34:29 EDT 2024 Sat Sep 28 08:47:25 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | rasagiline inhibitor constant l-deprenyl (selegiline) rivastigmine Alzheimer’s disease enzyme inhibition donepezil multitarget-directed ligand (MTDL) galantamine |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c541t-4140d1e1a12d53b315d3d364a9070babd19e89188275c856018f6401de54abf3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 These authors contributed equally to this work. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152246/ |
PMID | 28714881 |
PQID | 2108560165 |
PQPubID | 2032355 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_deb3d502895c473da70df84f8fef60cd pubmedcentral_primary_oai_pubmedcentral_nih_gov_6152246 proquest_miscellaneous_1920193859 proquest_journals_2108560165 crossref_primary_10_3390_molecules22071192 pubmed_primary_28714881 |
PublicationCentury | 2000 |
PublicationDate | 2017-07-15 |
PublicationDateYYYYMMDD | 2017-07-15 |
PublicationDate_xml | – month: 07 year: 2017 text: 2017-07-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Molecules (Basel, Switzerland) |
PublicationTitleAlternate | Molecules |
PublicationYear | 2017 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | ref57 ref56 ref208 ref59 ref58 ref206 ref203 ref52 ref204 ref55 ref201 ref54 ref202 ref209 McDonald (ref134) 2002 Ramsay (ref25) 1994; 41 ref210 ref211 ref51 ref50 ref218 ref45 ref219 ref48 ref216 ref47 ref217 ref42 ref214 ref41 ref215 ref44 ref212 ref43 ref213 ref49 ref8 ref7 Wei (ref46) 2012; 28 ref9 ref4 ref3 ref6 ref5 ref101 ref222 ref40 ref220 ref34 ref37 ref36 Tipton (ref159) 1983; 209 ref31 ref30 ref33 ref32 ref39 ref38 Kinemuchi (ref151) 1982; 31 ref24 ref23 Okabe (ref207) 1977; 80 ref26 ref20 ref22 ref21 ref28 ref27 ref29 Curet (ref69) 1996; 277 Finberg (ref53) 2011; 100 ref200 ref128 ref129 ref97 ref126 ref96 ref127 ref99 ref124 ref98 ref125 Michel (ref188) 1949; 34 Saura (ref16) 1992; 12 ref93 ref92 ref95 Tipton (ref144) 2011; 100 ref94 ref132 ref130 ref91 ref90 ref89 ref139 Weissbach (ref164) 1960; 235 ref86 ref85 ref138 ref88 ref135 ref87 ref136 ref82 ref81 ref145 ref142 ref83 ref141 ref80 ref79 ref108 ref229 ref78 ref109 ref106 ref227 ref107 ref228 ref75 ref104 ref225 ref74 ref105 ref226 ref77 ref223 ref76 ref224 Shaw (ref100) 1949; 2 ref71 ref111 ref232 ref70 ref112 ref233 ref73 ref230 ref72 ref110 ref231 ref68 ref119 ref67 ref117 ref118 ref64 ref115 ref236 ref63 ref116 ref66 ref113 ref234 ref65 ref114 ref235 ref60 ref122 ref123 ref62 ref120 ref61 ref121 ref168 ref169 ref170 Berman (ref102) 1992; 41 ref177 ref178 ref175 ref176 ref173 ref174 ref171 ref172 Bortolato (ref35) 2011; 100 ref179 Bolea (ref10) 2011; 54 ref180 ref181 Inoue (ref163) 1999; 291 ref189 ref186 ref187 ref184 ref185 Villatte (ref205) 2001; 30 ref182 ref183 ref148 ref149 ref146 ref147 ref155 ref156 ref154 ref152 ref150 ref157 Rudolph (ref137) 1979; 63 ref158 ref166 ref167 ref165 ref162 ref160 ref161 ref13 ref12 Copeland (ref131) 2005; Volume 46 ref15 ref14 ref11 Tipton (ref143) 1996 ref17 ref19 ref18 Shafferman (ref84) 1992; 11 ref2 ref1 ref191 ref192 ref190 Kitz (ref153) 1962; 237 ref199 ref197 ref198 TR (ref103) 1990; 87 ref195 ref196 ref193 ref194 Tipton (ref133) 2002; Volume 257 Schlappi (ref221) 1985; 35 Dowd (ref140) 1965; 240 |
References_xml | – ident: ref85 doi: 10.1016/0197-0186(92)90189-X – ident: ref82 doi: 10.1038/nrn1035 – ident: ref2 doi: 10.1517/13543776.2015.1090973 – ident: ref54 doi: 10.1021/ar00056a003 – ident: ref179 doi: 10.1021/bi7019707 – volume: 30 start-page: 81 year: 2001 ident: ref205 article-title: Acetylcholinesterase assay for rapid expression screening in liquid and solid media publication-title: Biotechniques doi: 10.2144/01301st04 contributor: fullname: Villatte – ident: ref166 doi: 10.1006/abio.1993.1464 – ident: ref19 doi: 10.1021/bi00060a003 – ident: ref4 doi: 10.3389/fnins.2016.00265 – ident: ref181 doi: 10.1006/bbrc.1995.1079 – ident: ref190 doi: 10.1515/znc-2006-3-423 – ident: ref38 doi: 10.1016/S0361-9230(98)00111-7 – ident: ref226 doi: 10.1016/j.bcp.2015.01.017 – ident: ref44 doi: 10.1111/j.1471-4159.2005.03573.x – ident: ref126 doi: 10.1212/WNL.0b013e318216eb7b – volume: 2 start-page: 868 year: 1949 ident: ref100 article-title: Some aspects of the pharmacology of morphine with special reference to its antagonism by 5-amino-acridine and other chemically related compounds publication-title: Med. J. Aust. doi: 10.5694/j.1326-5377.1949.tb37429.x contributor: fullname: Shaw – ident: ref230 doi: 10.1016/j.neuropharm.2016.10.028 – ident: ref186 doi: 10.1517/17460441.2012.729037 – ident: ref227 doi: 10.1021/acschemneuro.6b00377 – ident: ref234 doi: 10.1016/j.ejmech.2016.03.084 – ident: ref182 doi: 10.1016/j.bmc.2007.05.021 – ident: ref149 doi: 10.1111/j.1471-4159.1979.tb02296.x – ident: ref18 doi: 10.1016/j.abb.2007.05.006 – ident: ref75 doi: 10.1016/S0896-6273(01)00584-0 – ident: ref202 doi: 10.3390/ijms12042631 – ident: ref9 doi: 10.1007/s12031-008-9139-6 – ident: ref87 doi: 10.1017/S1461145705005833 – ident: ref73 doi: 10.1007/s00441-006-0239-8 – ident: ref79 doi: 10.1074/jbc.M210241200 – ident: ref57 doi: 10.1021/ja101557k – ident: ref196 doi: 10.1016/j.tiv.2009.11.023 – ident: ref135 doi: 10.1002/0471141755.tx0421s30 – ident: ref68 doi: 10.1002/chin.199743321 – ident: ref124 doi: 10.1073/pnas.1301814110 – ident: ref112 doi: 10.1021/jm8002075 – ident: ref128 doi: 10.1002/14651858.CD005593 – ident: ref107 doi: 10.1016/j.cbi.2012.10.024 – ident: ref111 doi: 10.1111/j.1600-0773.1981.tb03263.x – ident: ref129 doi: 10.1039/C6RA03455A – ident: ref20 doi: 10.1146/annurev.neuro.22.1.197 – ident: ref98 doi: 10.12659/MSM.892982 – volume: 31 start-page: 959 year: 1982 ident: ref151 article-title: Time-dependent inhibition of monoamine-oxidase by beta—Phenethylamine publication-title: Biochem. Pharmacol. doi: 10.1016/0006-2952(82)90327-6 contributor: fullname: Kinemuchi – ident: ref167 doi: 10.1006/abio.1996.0041 – ident: ref21 doi: 10.1038/nsb732 – ident: ref125 doi: 10.1038/aps.2016.78 – ident: ref70 doi: 10.1021/jm070677y – ident: ref154 doi: 10.1016/0006-2952(82)90575-5 – ident: ref5 doi: 10.3389/fnins.2016.00177 – volume: 28 start-page: 403 year: 2012 ident: ref46 article-title: Monoamine oxidase—A physically interacts with presenilin-1(m146v) in the mouse cortex publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-2011-111241 contributor: fullname: Wei – ident: ref172 doi: 10.1039/c0an00168f – ident: ref174 doi: 10.1016/j.ab.2016.06.020 – ident: ref23 doi: 10.1016/j.jmb.2004.02.032 – ident: ref228 doi: 10.1089/ars.2011.4279 – ident: ref3 doi: 10.1016/j.ejmech.2016.03.002 – ident: ref215 doi: 10.3389/fnins.2016.00205 – ident: ref214 doi: 10.3390/molecules21030362 – ident: ref22 doi: 10.2210/pdb2bxr/pdb – volume: Volume 46 year: 2005 ident: ref131 contributor: fullname: Copeland – ident: ref26 doi: 10.1016/0006-2952(80)90202-6 – ident: ref80 doi: 10.1111/j.1432-1033.1981.tb06447.x – ident: ref229 doi: 10.1016/j.bmc.2017.02.027 – ident: ref27 doi: 10.1007/s00702-011-0657-y – ident: ref220 doi: 10.1126/science.7838 – ident: ref67 doi: 10.1016/0223-5234(90)90131-L – ident: ref185 doi: 10.1177/000456327901600114 – ident: ref198 doi: 10.1016/j.ab.2007.07.023 – volume: 277 start-page: 253 year: 1996 ident: ref69 article-title: Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. 1. Biochemical profile publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Curet – ident: ref61 doi: 10.1007/s00406-006-0660-8 – ident: ref110 doi: 10.1002/14651858.CD003155 – ident: ref6 doi: 10.1007/s10822-014-9816-1 – ident: ref89 doi: 10.3390/ijms15069809 – ident: ref177 doi: 10.1042/bj1250521 – ident: ref206 doi: 10.1016/j.talanta.2012.10.085 – ident: ref233 doi: 10.2174/0929867322666150114163051 – volume: 100 start-page: 13 year: 2011 ident: ref35 article-title: Behavioral outcomes of monoamine oxidase deficiency: Preclinical and clinical evidence publication-title: Int. Rev. Neurobiol. doi: 10.1016/B978-0-12-386467-3.00002-9 contributor: fullname: Bortolato – ident: ref147 doi: 10.1016/0005-2744(69)90420-3 – ident: ref59 doi: 10.1111/j.1365-2125.2006.02627.x – ident: ref130 doi: 10.1002/1098-2299(200007/08)50:3/4<216::AID-DDR4>3.0.CO;2-Z – ident: ref208 doi: 10.1042/bj2250825 – ident: ref28 doi: 10.1021/jm800132g – ident: ref60 doi: 10.1023/B:CEMN.0000012725.31108.4a – ident: ref211 doi: 10.1007/s00044-013-0704-3 – ident: ref63 doi: 10.2174/156720506779025288 – ident: ref92 doi: 10.1021/ja0512780 – ident: ref168 doi: 10.1002/rcm.1415 – ident: ref47 doi: 10.1016/j.pneurobio.2016.04.001 – ident: ref49 doi: 10.1016/j.pneurobio.2015.07.002 – ident: ref101 doi: 10.3891/acta.chem.scand.15-1386 – ident: ref187 doi: 10.1042/bj1150465 – ident: ref66 doi: 10.1021/jm0400810 – ident: ref105 doi: 10.1042/bj1110487 – ident: ref52 doi: 10.1016/0006-2952(89)90522-4 – ident: ref74 doi: 10.1159/000065054 – ident: ref42 doi: 10.1007/s00702-007-0692-x – ident: ref113 doi: 10.2174/1570159X11311030006 – ident: ref189 doi: 10.1081/BIO-200027497 – ident: ref109 doi: 10.1136/pgmj.23.260.280 – ident: ref96 doi: 10.5041/RMMJ.10014 – ident: ref122 doi: 10.1002/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO;2-1 – ident: ref176 doi: 10.1016/j.bmc.2016.12.029 – ident: ref56 doi: 10.1111/febs.13260 – ident: ref235 doi: 10.3389/fnins.2016.00375 – ident: ref65 doi: 10.1111/j.1527-3458.2003.tb00245.x – ident: ref50 doi: 10.2174/138945012799499794 – volume: 100 start-page: 43 year: 2011 ident: ref144 article-title: Kinetic behavior and reversible inhibition of monoamine oxidases-enzymes that many want dead publication-title: Int. Rev. Neurobiol. doi: 10.1016/B978-0-12-386467-3.00003-0 contributor: fullname: Tipton – ident: ref51 doi: 10.1021/bi8002814 – ident: ref165 doi: 10.1016/0003-2697(78)90344-5 – ident: ref183 doi: 10.1016/j.ejmech.2013.12.028 – volume: 34 start-page: 1564 year: 1949 ident: ref188 article-title: An electrometric method for the determination of red blood cell and plasma cholinesterase activity publication-title: J. Lab. Clin. Med. contributor: fullname: Michel – ident: ref222 doi: 10.1007/s11064-010-0238-8 – ident: ref232 doi: 10.1016/j.pneurobio.2015.12.003 – ident: ref76 doi: 10.1042/bj3140817 – ident: ref91 doi: 10.1016/j.cbi.2016.04.009 – volume: 63 start-page: 22 year: 1979 ident: ref137 article-title: Techniques in coupled enzyme assays publication-title: Methods Enzymol. doi: 10.1016/0076-6879(79)63004-5 contributor: fullname: Rudolph – ident: ref184 doi: 10.1016/j.bbapap.2014.03.006 – ident: ref152 doi: 10.1016/0006-2952(74)90251-2 – ident: ref224 doi: 10.5607/en.2013.22.1.1 – ident: ref55 doi: 10.1016/j.bmc.2005.02.061 – ident: ref162 doi: 10.1016/0006-2952(95)00145-P – ident: ref43 doi: 10.1073/pnas.0601515103 – ident: ref204 doi: 10.1021/ac60220a031 – start-page: 115 year: 1996 ident: ref143 article-title: Patterns of enzyme inhibition contributor: fullname: Tipton – ident: ref219 doi: 10.1007/BF00978365 – volume: 11 start-page: 3561 year: 1992 ident: ref84 article-title: Substrate-inhibition of acetylcholinesterase - residues affecting signal transduction from the surface to the catalytic center publication-title: EMBO J. doi: 10.1002/j.1460-2075.1992.tb05439.x contributor: fullname: Shafferman – ident: ref62 doi: 10.1002/ejoc.201100873 – ident: ref155 doi: 10.1111/j.1432-1033.1984.tb08079.x – ident: ref34 doi: 10.3389/fnins.2016.00541 – ident: ref231 doi: 10.1016/j.bmc.2015.04.009 – volume: 240 start-page: 863 year: 1965 ident: ref140 article-title: A comparison of estimates of Michaelis—Menten kinetic constants from various linear transformations publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(17)45254-9 contributor: fullname: Dowd – ident: ref90 doi: 10.4049/jimmunol.176.1.27 – ident: ref195 doi: 10.1016/j.mex.2014.10.010 – ident: ref1 doi: 10.1038/nrd892 – ident: ref160 doi: 10.1016/0005-2744(81)90034-6 – ident: ref36 doi: 10.1001/archpsyc.63.11.1209 – ident: ref209 doi: 10.1016/j.vascn.2015.07.002 – ident: ref173 doi: 10.1016/j.cclet.2008.05.032 – ident: ref8 doi: 10.2741/3069 – ident: ref32 doi: 10.1016/j.bmc.2014.12.063 – ident: ref33 doi: 10.1016/j.phrs.2010.09.001 – ident: ref71 doi: 10.1517/13543776.2014.982535 – ident: ref178 doi: 10.1073/pnas.85.13.4934 – ident: ref201 doi: 10.1042/bj0780769 – ident: ref17 doi: 10.1016/S0306-4522(96)83013-2 – ident: ref150 doi: 10.1038/sj.bjp.0707430 – ident: ref108 doi: 10.1038/srep37574 – volume: 41 start-page: 412 year: 1992 ident: ref102 article-title: Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase publication-title: Mol. Pharmacol. contributor: fullname: Berman – ident: ref139 doi: 10.1016/j.pisc.2014.02.012 – volume: 80 start-page: 87 year: 1977 ident: ref207 article-title: New enzymatic assay of cholinesterase activity publication-title: Clin. Chim. Acta doi: 10.1016/0009-8981(77)90267-4 contributor: fullname: Okabe – ident: ref14 doi: 10.1016/j.ejmech.2016.09.041 – volume: 209 start-page: 235 year: 1983 ident: ref159 article-title: The enzyme-activated irreversible inhibition of type-B monoamine-oxidase by 3-(4-(3-chlorophenyl)methoxy phenyl)-5-(methylamino)methyl -2-oxazolidinone methanesulfonate (compound MD 780236) and the enzyme-catalyzed oxidation of this compound as competing reactions publication-title: Biochem. J. doi: 10.1042/bj2090235 contributor: fullname: Tipton – ident: ref197 doi: 10.1016/S0009-8981(99)00144-8 – volume: 41 start-page: 17 year: 1994 ident: ref25 article-title: Kinetic-properties of cloned human liver monoamine-oxidase-A publication-title: J. Neural Transm.-Suppl. contributor: fullname: Ramsay – ident: ref170 doi: 10.1016/j.ab.2006.09.035 – ident: ref194 doi: 10.1016/S0003-2697(02)00506-7 – ident: ref120 doi: 10.1254/jjp.89.7 – ident: ref138 doi: 10.1515/znc-2007-1-225 – ident: ref141 doi: 10.1021/bi00708a010 – ident: ref88 doi: 10.1073/pnas.0508575102 – ident: ref93 doi: 10.1016/j.cbi.2008.05.035 – ident: ref7 doi: 10.1101/lm.026070.112 – ident: ref86 doi: 10.2174/1567205054367838 – volume: 35 start-page: 800 year: 1985 ident: ref221 article-title: The lack of hepatotoxicity in the rat with the new and reversible MAO-A inhibitor moclobemide in contrast to iproniazid publication-title: Arzneim.-Forsch./Drug Res. contributor: fullname: Schlappi – ident: ref30 doi: 10.1038/npp.2014.214 – ident: ref77 doi: 10.1126/science.1678899 – ident: ref31 doi: 10.1586/14737175.2016.1150783 – ident: ref78 doi: 10.1042/bj2600625 – ident: ref191 doi: 10.1016/S0968-0896(99)00149-2 – volume: 291 start-page: 856 year: 1999 ident: ref163 article-title: Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinyl derivatives publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Inoue – ident: ref114 doi: 10.1212/WNL.42.5.946 – ident: ref192 doi: 10.1016/j.talanta.2009.12.052 – ident: ref236 doi: 10.1038/sj.bjc.6601361 – ident: ref142 doi: 10.1093/emboj/cdg005 – ident: ref158 doi: 10.1016/0006-2952(94)90123-6 – ident: ref45 doi: 10.1007/s00702-011-0616-7 – ident: ref121 doi: 10.1021/acschemneuro.5b00040 – ident: ref123 doi: 10.1038/bjp.2008.185 – ident: ref94 doi: 10.1111/j.1742-4658.2007.06238.x – ident: ref104 doi: 10.1042/bj0460451 – ident: ref146 doi: 10.1042/bj1350101 – ident: ref210 doi: 10.3390/ijms17040525 – ident: ref218 doi: 10.1093/ijnp/pyv078 – ident: ref212 doi: 10.1073/pnas.68.8.1678 – ident: ref95 doi: 10.2174/138161206775193127 – ident: ref127 doi: 10.1371/journal.pone.0074916 – ident: ref200 doi: 10.1136/jmg.7.4.351 – ident: ref12 doi: 10.1016/j.ejmech.2015.03.040 – ident: ref213 doi: 10.1080/14756366.2016.1186019 – ident: ref225 doi: 10.1016/j.ejmech.2014.01.060 – ident: ref148 doi: 10.1111/j.1471-4159.1983.tb11312.x – volume: Volume 257 start-page: 1 year: 2002 ident: ref133 article-title: Principles of enzyme assay and kinetic studies contributor: fullname: Tipton – ident: ref216 doi: 10.1016/j.bmc.2016.02.023 – ident: ref48 doi: 10.1016/j.pneurobio.2016.03.004 – ident: ref72 doi: 10.1021/acs.jmedchem.6b00562 – ident: ref175 doi: 10.1021/acs.analchem.5b04303 – ident: ref117 doi: 10.1155/2012/728983 – ident: ref145 doi: 10.1042/bj1290197 – ident: ref11 doi: 10.3389/fnins.2016.00294 – ident: ref81 doi: 10.1002/(SICI)1096-9861(19980413)393:3<374::AID-CNE8>3.0.CO;2-Z – ident: ref156 doi: 10.1021/bi020016x – ident: ref40 doi: 10.1523/JNEUROSCI.2037-10.2010 – ident: ref29 doi: 10.1002/syn.890180203 – ident: ref37 doi: 10.1002/jlcr.3247 – ident: ref41 doi: 10.1074/jbc.M111.241422 – ident: ref223 doi: 10.1023/A:1006982732681 – ident: ref106 doi: 10.1007/s00204-017-1946-5 – ident: ref119 doi: 10.3233/JAD-2007-11412 – ident: ref58 doi: 10.1016/S1570-9639(03)00062-1 – year: 2002 ident: ref134 article-title: Kinetics of catalyzed reactions—Biological contributor: fullname: McDonald – ident: ref157 doi: 10.1042/bj2400379 – volume: 87 start-page: 245 year: 1990 ident: ref103 article-title: Mechanism of action of organophosphorus and carbamate insecticides publication-title: Environ. Health Perspect. doi: 10.1289/ehp.9087245 contributor: fullname: TR – volume: 237 start-page: 3245 year: 1962 ident: ref153 article-title: Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)50153-8 contributor: fullname: Kitz – ident: ref132 doi: 10.1002/0471227617 – volume: 100 start-page: 169 year: 2011 ident: ref53 article-title: Selective inhibitors of monoamine oxidase type B and the “cheese effect” publication-title: Int. Rev. Neurobiol. doi: 10.1016/B978-0-12-386467-3.00009-1 contributor: fullname: Finberg – ident: ref116 doi: 10.1016/j.bmc.2011.12.042 – ident: ref180 doi: 10.1016/j.cbpb.2011.02.002 – ident: ref24 doi: 10.1038/nrn1883 – ident: ref136 doi: 10.1021/cr900214c – volume: 235 start-page: 1160 year: 1960 ident: ref164 article-title: A rapid spectrophotometric assay of Monoamine Oxidase based on the rate of disappearance of kynuramine publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)69497-9 contributor: fullname: Weissbach – ident: ref203 doi: 10.1021/ac60122a029 – ident: ref64 doi: 10.1016/0197-0186(90)90154-L – ident: ref118 doi: 10.1111/j.1527-3458.2001.tb00205.x – ident: ref171 doi: 10.1021/ja058519o – volume: 54 start-page: 8251 year: 2011 ident: ref10 article-title: Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease publication-title: J. Med. Chem. doi: 10.1021/jm200853t contributor: fullname: Bolea – ident: ref99 doi: 10.1038/35067589 – ident: ref161 doi: 10.1042/bj2270843 – ident: ref15 doi: 10.1126/science.3875898 – ident: ref115 doi: 10.2165/00139709-200625020-00004 – ident: ref13 doi: 10.1021/acs.jmedchem.5b00599 – ident: ref39 doi: 10.1016/j.pharmthera.2014.02.010 – volume: 12 start-page: 1977 year: 1992 ident: ref16 article-title: Quantitative enzyme autoradiography with H-3 Ro 41–1049 and H-3 Ro 19–6327 invitro—Localization and abundance of MAO-A and MAO-B in Rat CNS, peripheral organs, and human brain publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.12-05-01977.1992 contributor: fullname: Saura – ident: ref97 doi: 10.1074/jbc.M109.004952 – ident: ref83 doi: 10.1159/000151112 – ident: ref169 doi: 10.1038/nprot.2006.402 – ident: ref199 doi: 10.1002/dta.337 – ident: ref193 doi: 10.1016/0006-2952(61)90145-9 – ident: ref217 doi: 10.1097/00004714-200212000-00012 |
SSID | ssj0021415 |
Score | 2.603509 |
SecondaryResourceType | review_article |
Snippet | The actions of many drugs involve enzyme inhibition. This is exemplified by the inhibitors of monoamine oxidases (MAO) and the cholinsterases (ChE) that have... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1192 |
SubjectTerms | Alzheimer’s disease Amine oxidase (flavin-containing) Animals Cholinesterase Cholinesterase inhibitors Cholinesterase Inhibitors - chemistry Cholinesterase Inhibitors - pharmacology Cholinesterase Inhibitors - therapeutic use Cholinesterases - chemistry Cholinesterases - metabolism Computer Simulation donepezil Drug development Drug Discovery - methods Drug Evaluation, Preclinical Drugs Enzymatic activity Enzyme Activation - drug effects enzyme inhibition Enzymes galantamine Humans Inhibition inhibitor constant l-deprenyl (selegiline) Monoamine Oxidase - chemistry Monoamine Oxidase - metabolism Monoamine Oxidase Inhibitors - chemistry Monoamine Oxidase Inhibitors - pharmacology Monoamine Oxidase Inhibitors - therapeutic use multitarget-directed ligand (MTDL) Neurodegenerative Diseases - drug therapy Neurodegenerative Diseases - etiology Neurodegenerative Diseases - metabolism Neurodegenerative Diseases - pathology Neurotransmitter Agents - antagonists & inhibitors Neurotransmitter Agents - metabolism Pharmacology rasagiline Review rivastigmine Structure-Activity Relationship |
SummonAdditionalLinks | – databaseName: Open Access: DOAJ - Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9MwFLbQLuOCYPwKbMhInJCixbGduNxK12kgAZch7RY5fjbtocnUtNLGff_33ovT0gISF65xZDl-tt_35T1_j7F3pfOZl65InbFIUIQtUmNLm5aZCIiPBYiCbiN_-VpcfFefr_TVTqkvygmL8sBx4k4B2R5oiodpp0oJtswgGBVM8KHIHPSnr9AbMjVQLYF-KcYwJZL600UsNeu7PEeXGuOev7xQL9b_N4T5e6Lkjuc5f8weDZCRj-NQn7AHvjlih5NNpban7G68ldfkbeDT5uftwvNPzWxe9wlZH_iYxxgAp9-ufHpjSRO443S3hCMC5DupQ9QDbvTWLhB_8m83c0A_x20DfDKjAj-9sgI9Gvpvl7f8bLn-0T1jl-fTy8lFOpRXSJ1WYoWGURkIL6zIQctaCg0SZKEs8uWstjWIkTcjgRC81M4QczOhQDoGXitbB_mcHTRt418yDpkKMNLgrTHKQ2FKp52ngG4gtVWTsPeb2a6uo4hGheSDTFP9YZqEfSR7bF8k_ev-Aa6KalgV1b9WRcKON9ashk3ZVTndtCD5GZ2wt9tmtBXFSGzj23VX4QAQ9EqjRwl7EY2_HQmRSzzvRMLKvWWxN9T9lmY-6yW7ETeSct-r__Ftr9nDnLAFqXvqY3awWq79CSKjVf2m3wT3NcgR6w priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgHOCCynegICNxQooax3bi5YKW7S4FCbgUqbfI8djdPWxSNrtSy53_3Zkkm3YL4mpHlpVne954xm8Ye5c7n3jpstgZiw6KsFlsbG7jPBEB-bEAkdFr5G_fs-Of6uupPu0v3Jo-rXJ7JrYHNdSO7sgPU0qTJ-0Q_fH8V0xVoyi62pfQuMvuCVLCo5fis8-DwyXQOnWRTImu_eGyKzjrmzRFw9pFP69tUSvZ_y-eeTtd8ob9me2zhz1x5OMO6Ufsjq8es_uTbb22J-zPeBDZ5HXg0-r35dLzL9V8UbZpWR_4mHeRAE6Xr3x6YUkZuOH0woQjD-Q3EohoBNzutV0iC-U_LhaA1o7bCvhkTmV-Wn0FaurHr1eX_Gi1OWuespPZ9GRyHPdFFmKnlVgjPCoB4YUVKWhZSqFBgsyURa85KW0JYuTNSCARz7VrETAhQ6cMvFa2DPIZ26vqyr9gHBIVYKTBW2OUh8zkTjtPYd1AmqsmYu-3f7s476Q0CnRBCJriL2gi9onwGD4kFey2oV6dFf2mKsCXEjTFSrVTuQSbJxCMCib4kCUOInawRbPot2ZTXC-kiL0duhEripTYytebpsAJIPWVRo8i9rwDf5gJuZh46omI5TvLYmequz3VYt4KdyN7JP2-l_-f1iv2ICXuQOqd-oDtrVcb_xqZz7p80y7vK9oICAw priority: 102 providerName: ProQuest |
Title | Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28714881 https://www.proquest.com/docview/2108560165 https://search.proquest.com/docview/1920193859 https://pubmed.ncbi.nlm.nih.gov/PMC6152246 https://doaj.org/article/deb3d502895c473da70df84f8fef60cd |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbacoALKu_QsjISJ6R04ziOvdy2yy4FqaVCRdpb5PjRXYkk1WZXarnzv5nJY9UFTlxysBNrlBlrvvHMfCbknTQuctykoVEaAhSm01BpqUMZMQ_4mFmWYjfy-UV69j35MhfzPSL6XpimaN_ky5PyR3FSLhdNbeVNYYZ9ndjw8nwCXhh50Ib7ZF9y3ofoXZTFwCW16UsO8fywaG-ZdXUcgzcFPIP0vyAEGC7b8UUNZf-_cOaf5ZL3_M_skDzugCMdtwI-IXuufEoeTvr72p6RX-MtySatPJ2WP-8KRz-Xi2XelGV9oGPaZgIoHr7S6a1GZuCaYocJBRxI7xUQ4Qqw3StdAAqlX2-XFrwd1aWlkwVe89PwK-BQt361uqMfV5vr-jm5mk2vJmdhd8lCaETC1qCeJLLMMc1iK3jOmbDc8jTREDVHuc4tGzk1YgDEpTAK4zflUwjKrBOJzj1_QQ7KqnSvCLVR4u1IWKeVSpxNlTTCOEzreuRcVQF53__t7Kal0sggBEEtZX9pKSCnqI_ti8iC3QxUq-uss4XMupxbgblSYRLJrZaR9SrxyjufRsYG5LjXZtZtzTqLsd8CSWhEQN5up0FXmCnRpas2dQYCAPTlSowC8rJV_laS3ngCInfMYkfU3Rmw44a4u7Pb1__95RF5FCOsQGJPcUwO1quNewOgaJ0PYCvMJTzV7NOAPDidXlx-GzQHDINme_wG2HsVaQ |
link.rule.ids | 230,315,733,786,790,870,891,2115,12083,12792,21416,27955,27956,31752,31753,33406,33407,33777,33778,43343,43633,43838,53825,53827,74100,74390,74657 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Pb9MwFH6C7jAuiN_LNsBInJCixXGcuFxQVzp1sBWEirRb5NjO2kOT0bTSxp3_m_eSNFsBcbUjy8pn-33P7_l7AG8T4wInTOwbpdFB4Tr2lU60nwQ8R37MLY_pNfL5JB5_jz5dyIv2wq1q0yo3Z2J9UNvS0B35UUhp8qQdIj9c_fCpahRFV9sSGvdhhyQ3VQ92jkeTr986l4ujfWpimQKd-6NFU3LWVWGIprWJf95ao1q0_19M88-EyTsW6OQRPGypIxs0WD-Ge654ArvDTcW2p_Br0MlssjJno-LnzcKx02I2z-rErPdswJpYAKPrVza61qQNXDF6Y8KQCbI7KUQ0Am74Ui-Qh7Iv13OL9o7pwrLhjAr91AoL1NSOXy5v2Mfl-rJ6BtOT0XQ49tsyC76REV8hQFFgueOah1aKTHBphRVxpNFvDjKdWd53qs-RiifS1BioPEa3zDoZ6SwXz6FXlIXbA2aDKLd9aZ1WKnI2VomRxlFgNyfVVeXBu83fTq8aMY0UnRCCJv0LGg-OCY_uQ9LBrhvK5WXabqvUukxYSdFSaaJEWJ0ENldRrnKXx4GxHhxu0EzbzVmlt0vJgzddN2JFsRJduHJdpTgBJL9Cyb4HLxrwu5mQk4nnHvcg2VoWW1Pd7inms1q6G_kjKfjt_39ar2F3PD0_S89OJ58P4EFITIK0POUh9FbLtXuJPGiVvWoX-2_brAxj |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BkYBLxZuUAkbihBRtHMeJlwtatru0PAqHIvUWOX5097BJ2exKLXf-NzNJNu0C4mpHlpXP9nzjGX8D8DozLnLCpKFRGh0UrtNQ6UyHWcQ98mNueUqvkb8cp4ffk4-n8rTLf6q7tMrNmdgc1LYydEc-iClNnrRD5MB3aRHfDqbvzn-EVEGKIq1dOY2bcItINpVxUNMPvfPF0VK1UU2BnYNFW3zW1XGMRraNhF7ZpUa-_1-c88_UyWu2aHoPdjsSyUYt6vfhhisfwJ3xpnbbQ_g16gU3WeXZpPx5uXDsqJzNiyZF6y0bsTYqwOgilk0uNKkE14xemzDkhOxaMhGNgFu_0gtkpOzrxdyi5WO6tGw8o5I_jdYCNXXjV8tLdrBcn9WP4GQ6ORkfhl3BhdDIhK8QqiSy3HHNYytFIbi0woo00ehBR4UuLB86NeRIyjNpGjSUT9FBs04muvDiMeyUVemeArNR4u1QWqeVSpxNVWakcRTi9aS_qgJ4s_nb-Xkrq5GjO0LQ5H9BE8B7wqP_kBSxm4ZqeZZ3Gyy3rhBWUtxUmiQTVmeR9SrxyjufRsYGsL9BM--2aZ1fLaoAXvXdiBVFTXTpqnWd4wSQBgslhwE8acHvZ0LuJp6APIBsa1lsTXW7p5zPGhFvZJKk5bf3_2m9hNu4yvPPR8efnsHdmCgFiXrKfdhZLdfuORKiVfGiWem_AZOgDyk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+Enzyme+Inhibition%3A+A+Review+with+Examples+from+the+Development+of+Monoamine+Oxidase+and+Cholinesterase+Inhibitory+Drugs&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Ramsay%2C+Rona+R.&rft.au=Tipton%2C+Keith+F.&rft.date=2017-07-15&rft.pub=MDPI&rft.eissn=1420-3049&rft.volume=22&rft.issue=7&rft_id=info:doi/10.3390%2Fmolecules22071192&rft_id=info%3Apmid%2F28714881&rft.externalDBID=PMC6152246 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon |